e-learning
resources
Munich 2006
Tuesday 05.09.2006
Recent advances in the treatment of COPD and acute lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhibition of human lung fibroblast functions by roflumilast N-oxide
S. Boero, M. Silvestri, F. Sabatini, A. Nachira, G. A. Rossi (Genoa, Italy)
Source:
Annual Congress 2006 - Recent advances in the treatment of COPD and acute lung injury
Session:
Recent advances in the treatment of COPD and acute lung injury
Session type:
Thematic Poster Session
Number:
3845
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Boero, M. Silvestri, F. Sabatini, A. Nachira, G. A. Rossi (Genoa, Italy). Inhibition of human lung fibroblast functions by roflumilast N-oxide. Eur Respir J 2006; 28: Suppl. 50, 3845
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Roflumilast N-oxide reduces human fibroblast function
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Roflumilast N-oxide, a PDE4 inhibitor, curbs bleomycin-induced lung fibroblast activation
in vitro
Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Year: 2011
The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE
2
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Effects of aclidinium on human lung fibroblast activation
in vitro
Source: Annual Congress 2011 - Understanding disease and drug mechanisms
Year: 2011
Proteoglycan production in cultured human lung fibroblasts is synergistcally inhibited by combination of budesonide and formoterol
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003
COX inhibition enhances remodelling processes in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Effect of roflumilast N-oxide on non-typable
haemophilus influenzae
(NTHi) interaction with human airway epithelial A549 cells
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003
LATE-BREAKING ABSTRACT: Roflumilast and its active metabolite inhibit LPS-induced cytokines production from human parenchymal and bronchial explants: interaction with formoterol
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Modulation of TNFα-induced ICAM-1 expression in a human bronchial epithelial cell line (Beas-2B) by roflumilast N-oxide (RNO), salmeterol (Sal) and budesonide (Bud)
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007
The PDE4 inhibitor roflumilast N-oxide partly restored cigarette smoke (CS)-induced tight junction disassembly in human airway epithelial cells (Calu-3) – role of MAPK
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Statins inhibit human lung fibroblast production and activation of MMPs
Source: Eur Respir J 2007; 30: Suppl. 51, 692s
Year: 2007
Cytokine-induced production of eotaxin-3 by human lung epithelial cells is inhibited by levocetirizine
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005
HDAC2-independent anti-inflammatory effects of budesonide in human lung fibroblasts
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Rapid inhibitory effects of budesonide and formoterol on bradykinin-induced Ca
2+
mobilization in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Roflumilast N-oxide (RNO) alleviates from RSV-induced loss of ciliated cells and enhanced MUC5AC in differentiated human bronchial epithelial cells (D-HBE)
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
TGFβ-induced proteoglycan production and α-smooth muscle actin expression in cultured human lung fibroblasts is inhibited by combination of budesonide and formoterol
Source: Eur Respir J 2004; 24: Suppl. 48, 251s
Year: 2004
Dexamethasone and formoterol modulate human rhinovirus induced MMP-9 expression
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept